Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery

NACompletedINTERVENTIONAL
Enrollment

228

Participants

Timeline

Start Date

May 20, 2021

Primary Completion Date

February 13, 2024

Study Completion Date

February 13, 2024

Conditions
Cerebrospinal Fluid Leak
Interventions
DEVICE

LIQOSEAL

Adjunctive bioresorbable patch

DEVICE

DuraSeal, Adherus

synthetic absorbable sealants

Trial Locations (17)

10075

Lenox Hill Hospital, New York

32207

Baptist Health, Jacksonville

32224

Mayo Clinic, Jacksonville

45229

University of Cincinnatti, Cincinnati

55905

Mayo Clinic, Rochester, Rochester

75390

UT Southwestern Medical Center, Dallas

87131

University of New Mexico, Albuquerque

94305

Stanford University, Palo Alto

97239

OHSU, Portland

Unknown

University Hospitals of Innsbruck, Innsbruck

University Hospital Gent, Ghent

Universitätsklinikum Düsseldorf, Düsseldorf

UMM, Mannheim

Molinette Hospital, Torino

Elisabeth TweeSteden Ziekenhuis, Tilburg

UMCU, Utrecht

University Hospital Zurich, Zurich

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Polyganics BV

INDUSTRY

NCT04086550 - Evaluate the Safety and Efficacy of Dura Sealant Patch in Reducing CSF Leakage Following Elective Cranial Surgery | Biotech Hunter | Biotech Hunter